Quinidine Gluconate
NDC Package 68151-2701-0
Package Information
Quinidine Gluconate is quinidine is contraindicated in patients who are known to be allergic to it, or who have a history of immune thrombocytopenia or have developed thrombocytopenic purpura during prior therapy with quinidine or quinine (see WARNINGS).In the absence of a functioning artificial pacemaker, quinidine is also contraindicated in any patient whose cardiac rhythm is dependent upon a junctional or idioventricular pacemaker, including patients in complete atrioventricular block.Quinidine is also contraindicated in patients who, like those with myasthenia gravis, might be adversely affected by an anticholinergic agent. Marketed by Carilion Materials Management, this product is identified by NDC 68151-2701 and is authorized under FDA application ANDA089338.
Identification & Billing
- RxCUI: 852920 - quiNIDine gluconate 324 MG Extended Release Oral Tablet
- RxCUI: 852920 - quinidine gluconate 324 MG Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68151 - Carilion Materials Management
- 68151-2701 - Quinidine Gluconate
- 68151-2701-0 - 1 TABLET, EXTENDED RELEASE in 1 PACKAGE
- 68151-2701 - Quinidine Gluconate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68151-2701-0 identifies a specific commercial package of 1 tablet, extended release in 1 package of Quinidine Gluconate, labeled by Carilion Materials Management. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Carilion Materials Management on February 10, 1987. The current certification is valid through December 31, 2018.
How is this Carilion Materials Management product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68151270100. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.